2 unknown, 1 completed, 1 not yet recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Jun Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors Human Interleukin-11, Romiplostim N01 - Solid Tumor Malignancies, Cancer, CTIT-Chemotherapy Induced Thrombocytopenia | Not applicable | Not yet recruiting | Jun wang | 106 | 2025-09-01 | 2025-09-22 |
| Thymosin Alpha-1 for irAE Secondary to ICIs Thymosin Alpha1, Immunosuppressant - IrAE | Phase 4 | Unknown | Jun Wang | 40 | 2023-09-01 | 2023-12-20 |
| Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis Adenocarcinoma of Lung | Unknown | Jun Wang | 450 | 2021-01-01 | 2021-01-05 | |
| the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort intravenous sufentanil, subcutaneous sufentanil, intravenous hydromorphone - Analgesia, Patient-Controlled | Phase 4 | Completed | Jun Wang | 600 | 2019-10-08 | 2021-02-09 |
Adenocarcinoma of Lung (1) · Agnosia (1) · Neoplasms (1) · Thrombocytopenia (1)
Cortisone (1) · Dexmedetomidine (1) · Immunosuppressive Agents (1) · Mycophenolic Acid (1) · Prednisone (1) · Tacrolimus (1) · Thymalfasin (1)
China (3)
PMID 23050812, PMID 23327199, PMID 28394330, PMID 32817121, PMID 33952398, PMID 34408744, PMID 35870709